Short Sleep Duration Is Related to Emerging Cardiovascular Risk Factors in Obese Children

María Navarro-Solera1, Joaquín Carrasco-Luna, Gonzalo Pin-Arboledas

  • 1*Department of Pediatrics, Obstetrics, and Gynecology, University of Valencia †Department of Experimental Science, School Catholic University of Valencia ‡Sleep Unit, Hospital Quirón §Department of Preventive Medicine and Public Health, University of Valencia ||Department of Pediatrics, Dr Peset University Hospital, Valencia, Spain.

Insights

Short sleep duration in obese children is linked to increased central obesity and higher risks for cardiovascular issues, including elevated blood pressure and homocysteine levels. This highlights the importance of adequate sleep for pediatric metabolic health.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Sleep Medicine

Background:

  • Childhood obesity is a growing public health concern.
  • Obesity is associated with an increased risk of cardiovascular disease.
  • Sleep disturbances are common in children and may impact metabolic health.

Purpose of the Study:

  • To investigate the association between sleep duration and cardiovascular risk factors in obese children.
  • To identify specific metabolic and clinical markers influenced by sleep duration in this population.

Main Methods:

  • Cross-sectional analysis of 90 obese children (ages 7-16).
  • Sleep duration assessed using the BEARS questionnaire and National Sleep Foundation criteria.
  • Evaluated various biochemical markers, including glucose, lipids, inflammatory markers, and adipokines.
  • Statistical analysis using general lineal and logistic regression models.

Main Results:

  • Short sleep duration was significantly associated with more severe central obesity.
  • Independent predictors of short sleep duration included increased mean arterial pressure, homocysteine, retinol-binding protein 4 (RBP4), and thyroid-stimulating hormone (TSH).
  • No significant association was found between sleep duration and inflammatory markers or adipokines.

Conclusions:

  • Inadequate sleep duration exacerbates obesity severity in children.
  • Short sleep is a significant risk factor for developing cardiovascular issues in obese children.
  • Findings underscore the critical role of sufficient sleep in managing pediatric obesity and preventing cardiometabolic complications.
Abstract

Related Concept Videos

Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
1.3K
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
803
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
404
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
346